Nutra Pharma Corp (NPHC) Amortizatization of Intangibles (2013 - 2026)

Nutra Pharma has disclosed Amortizatization of Intangibles across 13 years of filings, most recently posting $55400.0 for Q2 2026.

• In Q2 2026, Amortizatization of Intangibles rose 4.36% year-over-year to $55400.0; the TTM figure through Jun 2026 stood at $263232.0 (up 71.06% YoY), while the FY2025 annual figure was $286592.0, up 113.73% from the prior year.
• Amortizatization of Intangibles came in at $55400.0 for Q2 2026 at Nutra Pharma, down from $61325.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $133610.0 in Q1 2022 to a low of $16590.0 in Q3 2023.
• Average Amortizatization of Intangibles over 5 years is $62757.1, with a median of $56323.0 recorded in 2025.
• Year-over-year, Amortizatization of Intangibles sank 86.6% in 2023 and jumped 246.39% in 2025.
• Over 5 years, Amortizatization of Intangibles stood at $132876.0 in 2022, then slumped by 83.53% to $21884.0 in 2023, then gained by 10.24% to $24125.0 in 2024, then surged by 228.39% to $79224.0 in 2025, then sank by 30.07% to $55400.0 in 2026.
• Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $55400.0 in Q2 2026, $61325.0 in Q1 2026, and $79224.0 in Q4 2025.